Impact of 18-Fluorodeoxyglucose Positron Emission Tomography on the Management of Pancreatic Cancer
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 14 (7) , 1151-1158
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Preoperative Staging of Lung Cancer with Combined PET–CTNew England Journal of Medicine, 2009
- Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)Journal of Experimental & Clinical Cancer Research, 2008
- Management and Outcomes of Postpancreatectomy Fistula, Leak, and Abscess: Results of 908 Patients Resected at a Single Institution Between 2000 and 2005Journal of the American College of Surgeons, 2008
- Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patientsEuropean Journal of Cancer, 2008
- Preoperative evaluation of pancreatic adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Comprehensive Preoperative Assessment of Pancreatic Adenocarcinoma with 64-Section Volumetric CTRadioGraphics, 2007
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic CancerJournal of Clinical Gastroenterology, 2006
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Detection of liver metastases from pancreatic cancer using FDG PET.1999